This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Focal Nodular Hyperplasia (FNH) Is A Benign Liver Lesion Characterized By A Central Scar Surrounded By A Nodule, Or A Mass Of Abnormal Tissue. FNH Is Considered A Tumor-Like Lesion, But It Is Not A Cancerous Condition. FNH Is The Most Common Benign Liver Tumor, And Is Most Often Discovered During An Imaging Test, Such As An Ultrasound Or CT Scan. The Precise Cause Of FNH Is Unknown, But It Is Believed To Be Related To An Abnormality In The Way The Cells Of The Liver Divide. FNH Is Typically Found In Women Between The Ages Of 20 And 40, And It Is More Common In Those Who Use Oral Contraceptives. The Main Symptom Of FNH Is Usually Painless Abdominal Swelling, Although It Is Possible For The Lesion To Become Enlarged And Cause Discomfort. Other Symptoms May Include An Enlarged Liver, Jaundice, And Abdominal Pain. Diagnosis Of FNH Is Usually Made Through A Combination Of Physical Examination And Imaging Tests. A Biopsy May Also Be Performed To Confirm The Diagnosis. Treatment For FNH Is Usually Not Necessary, As It Is A Benign Condition. However, If The Lesion Is Causing Discomfort Or Is Large Enough To Interfere With Normal Functioning Of The Liver, It May Be Surgically Removed. In Summary, FNH Is A Benign Liver Lesion Characterized By A Central Scar Surrounded By A Nodule Of Abnormal Tissue. It Is Most Commonly Found In Women Between The Ages Of 20 And 40, And Is Usually Diagnosed Through A Combination Of Physical Examination And Imaging Tests. Treatment Is Typically Not Necessary, Although Surgery May Be Recommended If The Lesion Is Large Or Causing Discomfort.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States